Aging Population And Chronic Diseases Will Boost Heart Therapy Adoption
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
08 Aug 25
Updated
08 Aug 25
AnalystHighTarget's Fair Value
US$14.00
48.3% undervalued intrinsic discount08 Aug
US$7.24
1Y
-9.6%7D
4.3%